5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
Strasser S, Maier S, Leisser C, Saiko P, Madlener S, Bader Y, Bernhaus A, Gueorguieva M, Richter S, Mader RM, Wesierska-Gadek J, Schott H, Szekeres T, Fritzer-Szekeres M, Krupitza G.
Strasser S, et al. Among authors: schott h.
Differentiation. 2006 Dec;74(9-10):488-98. doi: 10.1111/j.1432-0436.2006.00082.x.
Differentiation. 2006.
PMID: 17177846